Immune Reconstitution Inflammatory Syndrome

Emergency Medicine Clinics of North America

Volumn 28, Issue 2, 2010, Pages 393-407

  Beatty, George W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiretroviral therapy; Complications of therapy; Immune reconstitution inflammatory syndrome; Immune restitution disease

Indexed keywords

ANTIRETROVIRUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; VIRUS RNA; ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ANTIVIRAL THERAPY; AUTOIMMUNE DISEASE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; FEVER; GRAVES DISEASE; HEADACHE; HEPATITIS; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; LUNG DISEASE; MYCOBACTERIOSIS; MYCOSIS; NEUROLOGIC DISEASE; NONHUMAN; OPPORTUNISTIC INFECTION; PARASITOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SARCOIDOSIS; SKIN DISEASE; SURGICAL DRAINAGE; VIRUS INFECTION; VIRUS LOAD; AIDS RELATED COMPLEX; ARTICLE; DIFFERENTIAL DIAGNOSIS; EMERGENCY MEDICINE; EMERGENCY TREATMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; IMMUNOLOGY; METHODOLOGY;

ABDOMINAL PAIN; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFLAMMATORY AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIAGNOSIS, DIFFERENTIAL; EMERGENCY MEDICINE; EMERGENCY TREATMENT; FEVER; GRAVES DISEASE; HEADACHE; HEPATITIS; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; LUNG DISEASES; RISK FACTORS; SARCOIDOSIS; SKIN DISEASES;

EID: 77952515470     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2010.01.004     Document Type: Review

References (65)

1. Shelburne S.A., Montes M., Hamill R.J. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006, 57(2):167-170.
2. French M.A., Lenzo N., John M., et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000, 1(2):107-115.
3. Shelburne S.A., Visnegarwala F., Darcourt J., et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005, 19(4):399-406.
4. Ratnam I., Chiu C., Kandala N.B., et al. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006, 42(3):418-427.
5. Jevtovic D.J., Salemovic D., Ranin J., et al. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Med 2005, 6(2):140-143.
6. Lawn S.D., Myer L., Bekker L.G., et al. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007, 21(3):335-341.
7. Shelburne S.A., Darcourt J., White A.C., et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005, 40(7):1049-1052.
8. Lortholary O., Fontanet A., Memain N., et al. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005, 19(10):1043-1049.
9. Lawn S.D., Bekker L.G., Myer L., et al. Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. AIDS 2005, 19(17):2050-2052.
10. Kambugu A., Meya D.B., Rhein J., et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 2008, 46(11):1694-1701.
11. French M.A. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009, 48(1):101-107.
12. Bicanic T., Meintjes G., Rebe K., et al. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr 2009, 51(2):130-134.
13. Sungkanuparph S., Jongwutiwes U., Kiertiburanakul S. Timing of cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in patients with AIDS and cryptococcal meningitis. J Acquir Immune Defic Syndr 2007, 45(5):595-596.
14. Singh N., Perfect J.R. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 2007, 7(6):395-401.
15. Sungkanuparph S., Filler S.G., Chetchotisakd P., et al. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. Clin Infect Dis 2009, 49(6):931-934.
16. Wislez M., Bergot E., Antoine M., et al. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 2001, 164(5):847-851.
17. Koval C.E., Gigliotti F., Nevins D., et al. Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection. Clin Infect Dis 2002, 35(4):491-493.
18. Shelburne S.A., Hamill R.J., Rodriguez-Barradas M.C., et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002, 81(3):213-227.
19. Jagannathan P., Davis E., Jacobson M., et al. Life-threatening immune reconstitution inflammatory syndrome after Pneumocystis pneumonia: a cautionary case series. AIDS 2009, 23(13):1794-1796.
20. De Lavaissiere M., Manceron V., Bouree P., et al. Reconstitution inflammatory syndrome related to histoplasmosis, with a hemophagocytic syndrome in HIV infection. J Infect 2009, 58(3):245-247.
21. Tremont-Lukats I.W., Garciarena P., Juarbe R., et al. The immune inflammatory reconstitution syndrome and central nervous system toxoplasmosis. Ann Intern Med 2009, 150(9):656-657.
22. Race E.M., Adelson-Mitty J., Kriegel G.R., et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998, 351(9098):252-255.
23. Phillips P., Bonner S., Gataric N., et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis 2005, 41(10):1483-1497.
24. Lawn S.D., Bekker L.G., Miller R.F. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005, 5(6):361-373.
25. Breton G., Duval X., Estellat C., et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004, 39(11):1709-1712.
26. Kumarasamy N., Chaguturu S., Mayer K.H., et al. Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr 2004, 37(5):1574-1576.
27. Burman W., Weis S., Vernon A., et al. Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis 2007, 11(12):1282-1289.
28. Leone S., Nicastri E., Giglio S., et al. Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: a systematic review. Int J Infect Dis August 3, 2009, [online].
29. Manabe Y.C., Campbell J.D., Sydnor E., et al. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007, 46(4):456-462.
30. Navas E., Martin-Davila P., Moreno L., et al. Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 2002, 162(1):97-99.
31. French M.A., Price P., Stone S.F. Immune restoration disease after antiretroviral therapy. AIDS 2004, 18(12):1615-1627.
32. Crothers K., Huang L. Pulmonary complications of immune reconstitution inflammatory syndromes in HIV-infected patients. Respirology 2009, 14(4):486-494.
33. Pepper D.J., Marais S., Maartens G., et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009, 48(11):e96-107.
34. Tsao Y.T., Wu Y.C., Yang C.S., et al. Immune reconstitution associated hypercalcemia. Am J Emerg Med 2009, 27(5):629. e1-3.
35. Weber E., Gunthard H.F., Schertler T., et al. Spontaneous splenic rupture as manifestation of the immune reconstitution inflammatory syndrome in an HIV type 1 infected patient with tuberculosis. Infection 2009, 37(2):163-165.
36. Olalla J., Pulido F., Rubio R., et al. Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease. Int J Tuberc Lung Dis 2002, 6(1):71-75.
37. Nguyen Q.D., Kempen J.H., Bolton S.G., et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol 2000, 129(5):634-639.
38. Zegans M.E., Walton R.C., Holland G.N., et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1998, 125(3):292-300.
39. Tsang C.S., Samaranayake L.P. Immune reconstitution inflammatory syndrome after highly active antiretroviral therapy: a review. Oral Dis 2009, [Epub ahead of print].
40. Martinez E., Gatell J., Moran Y., et al. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis 1998, 27(6):1510-1513.
41. Domingo P., Torres O.H., Ris J., et al. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. Am J Med 2001, 110(8):605-609.
42. Newsome S.D., Nath A. Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neurovirol 2009, 15(3):288-291.
43. Feller L., Lemmer J. Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma. Infect Agent Cancer 2008, 3:1.
44. Bower M., Nelson M., Young A.M., et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 2005, 23(22):5224-5228.
45. Letang E., Almeida J.M., Miro J.M., et al. Predictors of immune reconstitution inflammatory syndrome-associated with Kaposi sarcoma in Mozambique: a prospective study. J Acquir Immune Defic Syndr October 1, 2009, [online].
46. Connick E., Kane M.A., White I.E., et al. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Clin Infect Dis 2004, 39(12):1852-1855.
47. Godoy M.C., Rouse H., Brown J.A., et al. Imaging features of pulmonary Kaposi sarcoma-associated immune reconstitution syndrome. AJR Am J Roentgenol 2007, 189(4):956-965.
48. Martin J, Laker M, Clutter D, et al. Kaposi's Sarcoma-associated immune reconstitution inflammatory syndrome in Africa: initial findings from a prospective evaluation. In 16th Conference on retroviruses and opportunistic infections. Montreal, Canada, February 8-11, 2009.
49. Nathan R.V. Suspected immune reconstitution inflammatory syndrome associated with the proliferation of Kaposi's sarcoma during HAART. AIDS 2007, 21(6):775.
50. Crane H.M., Deubner H., Huang J.C., et al. Fatal Kaposi's sarcoma-associated immune reconstitution following HAART initiation. Int J STD AIDS 2005, 16(1):80-83.
51. Tan K., Roda R., Ostrow L., et al. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 2009, 72(17):1458-1464.
52. Ofotokun I., Smithson S.E., Lu C., et al. Liver enzymes elevation and immune reconstitution among treatment-naive HIV-infected patients instituting antiretroviral therapy. Am J Med Sci 2007, 334(5):334-341.
53. Crane M., Oliver B., Matthews G., et al. Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy. J Infect Dis 2009, 199(7):974-981.
54. Thio C.L., Locarnini S. Treatment of HIV/HBV coinfection: clinical and virologic issues. AIDS Rev 2007, 9(1):40-53.
55. Elston J.W., Thaker H. Immune reconstitution inflammatory syndrome. Int J STD AIDS 2009, 20(4):221-224.
56. Crum N.F., Ganesan A., Johns S.T., et al. Graves disease: an increasingly recognized immune reconstitution syndrome. AIDS 2006, 20(3):466-469.
57. Knysz B., Bolanowski M., Klimczak M., et al. Graves' disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review. Viral Immunol 2006, 19(1):102-107.
58. Vos F., Pieters G., Keuter M., et al. Graves' disease during immune reconstitution in HIV-infected patients treated with HAART. Scand J Infect Dis 2006, 38(2):124-126.
59. Haramati L.B., Lee G., Singh A., et al. Newly diagnosed pulmonary sarcoidosis in HIV-infected patients. Radiology 2001, 218(1):242-246.
60. Foulon G., Wislez M., Naccache J.M., et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 2004, 38(3):418-425.
61. Trevenzoli M., Cattelan A.M., Marino F., et al. Sarcoidosis and HIV infection: a case report and a review of the literature. Postgrad Med J 2003, 79(935):535-538.
62. Ferrand R.A., Cartledge J.D., Connolly J., et al. Immune reconstitution sarcoidosis presenting with hypercalcaemia and renal failure in HIV infection. Int J STD AIDS 2007, 18(2):138-139.
63. Huiras E., Preda V., Maurer T., et al. Cutaneous manifestations of immune reconstitution inflammatory syndrome. Curr Opin HIV AIDS 2008, 3(4):453-460.
64. Zolopa A., Andersen J., Powderly W., et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 2009, 4(5):e5575.
65. Murdoch D.M., Venter W.D., Van Rie A., et al. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 2007, 4:9.